Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 5 days ago Drug news

FDA’s Oncologic Drugs Advisory Committee voted 17-0 to recommend approval for ABP 215, a biosimilar for bevacizumab (Avastin)- Amgen + Allergan

The FDA’s Oncologic Drugs Advisory Committee voted 17-0 to recommend approval for ABP 215, a biosimilar for bevacizumab (Avastin) manufactured...

Added 13 days ago Drug news

Celgene and BeiGene Ltd collaborate to licence BGB A317 an advanced PD I inhibitor to Celgene and to licence certain Celgene products to BeiGene in China.

Celgene Corporation and BeiGene, Ltd. entered into a strategic collaboration to develop and commercialize BeiGene's investigational anti-programmed cell death protein...

Added 27 days ago Drug news

FDA approves Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express the BRAF V600E mutation.- Novartis

Novartis has announced the FDA approval of Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with metastatic non-small...

Search all news articles for Cancer of bronchus or lung
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone


IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress 2015

Visit IL-17A in Psoriasis


Guidelines

British Thoracic Society guidelines for the investigation and management of pulmonary nodules

The detection of pulmonary nodules is common. In populations undergoing CT screening and at high risk of lung cancer, nodules are...

Added 1 year ago

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest...

Added 2 years ago

ESR/ERS white paper on lung cancer screening

Lung cancer is the most frequently fatal cancer, with poor survival once the disease is advanced. Annual low-dose computed tomography...

Added 2 years ago

Search all guidelines for Cancer of bronchus or lung
 

Journal articles

Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Tobacco smoking is the world's leading cause of premature death and disability. Global targets to reduce premature deaths by 25% by 2025 will require a substantial increase in the number of smokers making a quit attempt...

Added 4 hours ago

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.

Background: BRAF mutations act as an oncogenic driver via the mitogen-activated protein kinase (MAPK) pathway in non-small cell lung cancer (NSCLC). BRAF inhibition has shown antitumour activity ...

Added 1 month ago

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib.

Lung carcinoma is the leading cause of death by cancer in the world. Nowadays, most patients will experience disease progression during or after first-line chemotherapy demonstrating the need for new, effective second-line treatments.

Added 1 month ago

Search all journal articles for Cancer of bronchus or lung
 

Clinical trials

A Study of CH5424802/RO5424802 in Patients With ALK-Rearranged Non-Small Cell Lung Cancer

This non-randomized, open-label, multicenter study will evaluate the safety and efficacy of CH5424802/RO5424802 in patients with ALK-rearranged non-small cell lung cancer who failed crizotinib treatment.

Added 3 months ago

A Study of RO5424802 in Patients With Non-Small Cell Lung Cancer Who Have ALK Mutation and Failed Crizotinib Treatment

This open-label, non-randomized, multicenter phase I/II study will evaluate the safety and efficacy of RO5424802 in patients with non-small cell lung cancer who have ALK mutation and failed crizotinib treatment.

Added 3 months ago

Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.

Dabrafenib is a potent and selective inhibitor of BRAF kinase activity. This is a Phase II, non-randomized, open-label study to assess the efficacy, safety, and tolerability of dabrafenib administered as ...

Added 1 month ago

Search all clinical trials for Cancer of bronchus or lung
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

CME

Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Non-small cell lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Lung cancer: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Cancer of bronchus or lung